2023 Q4 Form 10-Q Financial Statement

#000183943923000038 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $159.5M $143.6M
YoY Change 20.08% 21.37%
Cost Of Revenue $55.13M $51.38M
YoY Change 19.36% 18.97%
Gross Profit $104.4M $92.21M
YoY Change 20.46% 22.75%
Gross Profit Margin 65.45% 64.22%
Selling, General & Admin $113.9M $101.5M
YoY Change 9.15% 5.64%
% of Gross Profit 109.11% 110.1%
Research & Development $16.67M $14.06M
YoY Change 20.11% 13.33%
% of Gross Profit 15.96% 15.24%
Depreciation & Amortization $1.486M $1.511M
YoY Change 24.25% 25.92%
% of Gross Profit 1.42% 1.64%
Operating Expenses $130.6M $115.6M
YoY Change 10.44% 6.52%
Operating Profit -$26.18M -$23.37M
YoY Change -17.09% -30.0%
Interest Expense $1.153M $1.244M
YoY Change 185.4% 14.44%
% of Operating Profit
Other Income/Expense, Net -$1.745M $931.0K
YoY Change -2743.94% 109.21%
Pretax Income -$29.07M -$23.69M
YoY Change -8.88% -30.4%
Income Tax -$2.824M -$3.089M
% Of Pretax Income
Net Earnings -$26.25M -$20.60M
YoY Change -4.42% -29.11%
Net Earnings / Revenue -16.45% -14.34%
Basic Earnings Per Share -$0.15 -$0.12
Diluted Earnings Per Share -$0.15 -$0.12
COMMON SHARES
Basic Shares Outstanding 177.6M shares 176.9M shares
Diluted Shares Outstanding 177.6M shares 177.0M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.72M $54.30M
YoY Change -14.61% -44.68%
Cash & Equivalents $61.72M $54.28M
Short-Term Investments
Other Short-Term Assets $9.307M $6.630M
YoY Change 135.26% 166.27%
Inventory
Prepaid Expenses $12.86M $13.20M
Receivables $44.95M $34.74M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.517B $1.201B
YoY Change 12.37% 8.23%
LONG-TERM ASSETS
Property, Plant & Equipment $36.89M $37.72M
YoY Change 15.33% 22.52%
Goodwill $767.2M $764.6M
YoY Change -0.38% 2.06%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.921M $2.987M
YoY Change 4.55% 79.72%
Total Long-Term Assets $1.276B $1.286B
YoY Change -3.53% -1.37%
TOTAL ASSETS
Total Short-Term Assets $1.517B $1.201B
Total Long-Term Assets $1.276B $1.286B
Total Assets $2.793B $2.487B
YoY Change 4.5% 3.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.51M $20.34M
YoY Change 25.76% 31.12%
Accrued Expenses $61.81M $44.60M
YoY Change 8.59% -0.25%
Deferred Revenue $13.36M $13.10M
YoY Change 16.7% 15.56%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.426B $1.116B
YoY Change 11.75% 10.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $70.94M $71.27M
YoY Change -15.42% -10.44%
Total Long-Term Liabilities $70.94M $71.27M
YoY Change -15.42% -10.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.426B $1.116B
Total Long-Term Liabilities $70.94M $71.27M
Total Liabilities $1.525B $1.217B
YoY Change 8.55% 6.83%
SHAREHOLDERS EQUITY
Retained Earnings -$536.3M -$510.1M
YoY Change 18.68% 20.18%
Common Stock $178.0K $177.0K
YoY Change 1.14% 0.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.268B $1.269B
YoY Change
Total Liabilities & Shareholders Equity $2.793B $2.487B
YoY Change 4.5% 3.04%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$26.25M -$20.60M
YoY Change -4.42% -29.11%
Depreciation, Depletion And Amortization $1.486M $1.511M
YoY Change 24.25% 25.92%
Cash From Operating Activities $26.17M -$26.13M
YoY Change 367.02% 8.41%
INVESTING ACTIVITIES
Capital Expenditures $16.81M $1.435M
YoY Change 37.47% 333.53%
Acquisitions
YoY Change
Other Investing Activities -$49.62M $1.110M
YoY Change 146.33% -101.06%
Cash From Investing Activities -$66.43M -$13.59M
YoY Change 105.22% -88.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 285.1M -$16.47M
YoY Change 15.12% -97.87%
NET CHANGE
Cash From Operating Activities 26.17M -$26.13M
Cash From Investing Activities -66.43M -$13.59M
Cash From Financing Activities 285.1M -$16.47M
Net Change In Cash 244.9M -$56.19M
YoY Change 10.84% -93.86%
FREE CASH FLOW
Cash From Operating Activities $26.17M -$26.13M
Capital Expenditures $16.81M $1.435M
Free Cash Flow $9.358M -$27.56M
YoY Change -241.27% 12.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2023Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q3 us-gaap Revenues
Revenues
143588000 usd
CY2022Q3 us-gaap Revenues
Revenues
118303000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
51378000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
43185000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
92210000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
75118000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52778000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
48195000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48749000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47911000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14055000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12402000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
115582000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
108508000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-23372000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-33390000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1244000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1087000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
931000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
445000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23685000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34032000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3089000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4980000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-20596000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-29052000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175512577 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175512577 shares
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-20596000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-29052000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-168000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-423000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-174000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1700000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-342000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2123000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20938000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31175000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1284731000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-29052000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16951000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1293000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
4645000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2123000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1273859000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1273684000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-20596000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12915000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
418000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
4172000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-342000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1269415000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-20596000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-29052000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1511000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1200000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34183000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29676000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
14366000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
10028000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12915000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
16951000 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3098000 usd
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5000000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1291000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
562000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-61000 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-47000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-184000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-424000 usd
CY2023Q3 pycr Gain Loss On Lease Exit Including Accretion Expense
GainLossOnLeaseExitIncludingAccretionExpense
144000 usd
CY2022Q3 pycr Gain Loss On Lease Exit Including Accretion Expense
GainLossOnLeaseExitIncludingAccretionExpense
-509000 usd
CY2023Q3 us-gaap Accretion Expense
AccretionExpense
1030000 usd
CY2022Q3 us-gaap Accretion Expense
AccretionExpense
893000 usd
CY2023Q3 us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
23000 usd
CY2022Q3 us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
23000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
345000 usd
CY2023Q3 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
4172000 usd
CY2022Q3 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
4300000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16471000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-772641000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-56190000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-915716000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
822856000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
767207000 usd
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11000 usd
CY2022Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9000 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
145000 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6612000 usd
CY2023Q3 pycr Capital Lease Asset Obtained In Exchange For Capital Lease Liabilities
CapitalLeaseAssetObtainedInExchangeForCapitalLeaseLiabilities
3393000 usd
CY2022Q3 pycr Capital Lease Asset Obtained In Exchange For Capital Lease Liabilities
CapitalLeaseAssetObtainedInExchangeForCapitalLeaseLiabilities
0 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54277000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98161000 usd
CY2023Q3 pycr Funds Held For Clients Cash
FundsHeldForClientsCash
768579000 usd
CY2022Q3 pycr Funds Held For Clients Cash
FundsHeldForClientsCash
669046000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
822856000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
767207000 usd
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
Use of estimates The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the evaluation of potential impairment of goodwill and intangible assets and the valuation of stock-based compensation.The Company’s results of operations and financial condition can also be affected by economic, political, legislative, regulatory and legal actions, including but not limited to health epidemics and pandemics and their resulting economic impact. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, and government fiscal policies can have a significant effect on the Company’s results of operations and financial condition. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8296000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7032000 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
7831000 usd
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
5918000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12915000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
16951000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132708000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114169000 usd
CY2023Q3 pycr Implementation Fee Recognition Period
ImplementationFeeRecognitionPeriod
P24M
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18697000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17046000 usd
CY2023Q3 pycr Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
4888000 usd
CY2022Q3 pycr Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
4270000 usd
CY2023Q3 pycr Contract With Customer Liability Revenue Recognized Including Current Period Revenue
ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriodRevenue
4844000 usd
CY2022Q3 pycr Contract With Customer Liability Revenue Recognized Including Current Period Revenue
ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentPeriodRevenue
4709000 usd
CY2023Q3 pycr Contract With Customer Liability Foreign Exchange Gain Loss
ContractWithCustomerLiabilityForeignExchangeGainLoss
-29000 usd
CY2022Q3 pycr Contract With Customer Liability Foreign Exchange Gain Loss
ContractWithCustomerLiabilityForeignExchangeGainLoss
-117000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18712000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16490000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10646000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7126000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
940000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
217105000 usd
CY2023Q3 pycr Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
27086000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
14366000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
229825000 usd
CY2022Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
163474000 usd
CY2022Q3 pycr Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
21770000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
10028000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
175216000 usd
CY2023Q3 pycr Funds Held For Clients Amortized Cost
FundsHeldForClientsAmortizedCost
1037574000 usd
CY2023Q3 pycr Funds Held For Clients Gross Unrealized Gains
FundsHeldForClientsGrossUnrealizedGains
46000 usd
CY2023Q3 pycr Funds Held For Clients Gross Unrealized Losses
FundsHeldForClientsGrossUnrealizedLosses
4440000 usd
CY2023Q3 us-gaap Funds Held For Clients
FundsHeldForClients
1033180000 usd
CY2023Q2 pycr Funds Held For Clients Amortized Cost
FundsHeldForClientsAmortizedCost
1053309000 usd
CY2023Q2 pycr Funds Held For Clients Gross Unrealized Gains
FundsHeldForClientsGrossUnrealizedGains
93000 usd
CY2023Q2 pycr Funds Held For Clients Gross Unrealized Losses
FundsHeldForClientsGrossUnrealizedLosses
4246000 usd
CY2023Q2 us-gaap Funds Held For Clients
FundsHeldForClients
1049156000 usd
CY2023Q3 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
23652000 usd
CY2022Q3 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
143107000 usd
CY2023Q3 pycr Funds Held For Clients Maturities Year One
FundsHeldForClientsMaturitiesYearOne
844269000 usd
CY2023Q3 pycr Funds Held For Clients Maturities Year Two
FundsHeldForClientsMaturitiesYearTwo
71140000 usd
CY2023Q3 pycr Funds Held For Clients Maturities Year Three
FundsHeldForClientsMaturitiesYearThree
73867000 usd
CY2023Q3 pycr Funds Held For Clients Maturities Year Four
FundsHeldForClientsMaturitiesYearFour
21699000 usd
CY2023Q3 pycr Funds Held For Clients Maturities Year Five
FundsHeldForClientsMaturitiesYearFive
20639000 usd
CY2023Q3 pycr Funds Held For Clients Maturities After Year Five
FundsHeldForClientsMaturitiesAfterYearFive
1566000 usd
CY2023Q3 pycr Funds Held For Clients Maturities
FundsHeldForClientsMaturities
1033180000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60031000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55381000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22309000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20808000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37722000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34573000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1511000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1200000 usd
CY2023Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
138961000 usd
CY2023Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
125707000 usd
CY2023Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
80197000 usd
CY2023Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
71724000 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
58764000 usd
CY2023Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
53983000 usd
CY2023Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
8473000 usd
CY2022Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
6406000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
767738000 usd
CY2023Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-381000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
764619000 usd
CY2022Q3 pycr Partnership Agreement
PartnershipAgreement
P16Y
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
786685000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
786675000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
551912000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
526203000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
234773000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
260472000 usd
CY2023Q3 pycr Amortization Of Intangible Assets Excluding Capitalized Computer Software
AmortizationOfIntangibleAssetsExcludingCapitalizedComputerSoftware
25710000 usd
CY2022Q3 pycr Amortization Of Intangible Assets Excluding Capitalized Computer Software
AmortizationOfIntangibleAssetsExcludingCapitalizedComputerSoftware
23270000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
70825000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
42734000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
16232000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
12244000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
12244000 usd
CY2023Q3 pycr Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
80494000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29052000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
176953395 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176953395 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175512577 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175512577 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
234773000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
0 usd
CY2023Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
0 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
177104017 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
176535236 shares
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20596000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001839439-23-000038-index-headers.html Edgar Link pending
0001839439-23-000038-index.html Edgar Link pending
0001839439-23-000038.txt Edgar Link pending
0001839439-23-000038-xbrl.zip Edgar Link pending
a2024pycrq1-ex311xceosoxce.htm Edgar Link pending
a2024pycrq1-ex312xcfosoxce.htm Edgar Link pending
a2024pycrq1-ex321xceosecti.htm Edgar Link pending
a2024pycrq1-ex322xcfosecti.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pycr-20230930.htm Edgar Link pending
pycr-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pycr-20230930_cal.xml Edgar Link unprocessable
pycr-20230930_def.xml Edgar Link unprocessable
pycr-20230930_lab.xml Edgar Link unprocessable
pycr-20230930_pre.xml Edgar Link unprocessable
pycr-20230930_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending